“Efficacy and Safety of Tofacitinib vs Methotrexate in Patients with Moderate to Severe Plaque Psoriasis”, J Enam Med Col, vol. 11, no. 2, pp. 108–119, May 2021, doi: 10.3329/jemc.v11i2.65193.